Vins Pharmaceuticals

VINS Pharmaceuticals , established in 2017, Vinit Warghane (CEO) is actively involved in developing life-saving antisera against snake and scorpion bites; tetanus, diphtheria, gangrene antitoxins; and rabies immunoglobulins. These are manufactured in its state-of-the-art manufacturing facilities in Telangana along with 150-acre farms housing over 2000 equines and an animal laboratory for testing. Manned by experienced professionals, these fully automated facilities, conform to international norms, production standards and stringent quality controls.

VINS Pharmaceuticals facility is approved by PIC/s country and also by Kenya, Ethiopia, Ghana, Sudan, Jordan, etc.VINS Pharmaceuticalssupplies to over 70 countries spread across Asia, Africa, Middle East, Europe, Australia and North and South America. It also partners with international organizations such as WHO, UNICEF, UNDP and PAHO to help distribute its life-saving products.VINS Pharmaceuticals is recognised by the Department of Scientific and Industrial Research (DSIR) under the aegis of the Ministry of Science and Technology, Government of India.

VINS Pharmaceuticals remains deeply committed to adhering to global quality standards across all its corporate functions, Research Development, production, and testing facilities and continuously strives to maintain internationally benchmarked quality and regulatory systems.